AI assistant
Sending…
Skye Bioscience, Inc. — Director's Dealing 2015
Jan 13, 2015
34097_dirs_2015-01-12_0cb785f1-bf95-48ff-8eda-2fea5b8cd5b8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Nemus Bioscience, Inc. (NMUS)
CIK: 0001516551
Period of Report: 2015-01-09
Reporting Person: GEORGE THOMAS (Director)
More from Skye Bioscience, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
May 29
Delisting Announcement
2026
May 15
Annual Report
2026
Apr 16
Proxy Solicitation & Information Statement
2026
Apr 16
Board/Management Information
2026
Apr 3
Delisting Announcement
2026
Mar 19
Board/Management Information
2026
Feb 20
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10